Labcorp price target raised to $271 from $249 at Barclays

Barclays analyst Luke Sergott raised the firm’s price target on Labcorp (LH) to $271 from $249 and keeps an Equal Weight rating on the shares. The firm says the life science tools group will likely continue to work overall on the last estimate cut thesis and Q1 guides “coming in very conservative” that makes it hard to see companies missing targets.